A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-1)
Part of paid clinical trials in Northridge, California.
- Sponsor
- Generate Biomedicines
- Study ID
- NCT07276724
- Phase
- PHASE3
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 12 Years - 80 Years
- Healthy Volunteers
- Not accepted
Interventions
- GB-0895 — DRUGStudy Drug
- Placebo — DRUGPlacebo
Study Details
The objective of this study is to assess the potential for GB-0895 treatment to improve the health of adolescents and adults with severe asthma that is uncontrolled by inhaled corticosteroids (ICS) and conventional asthma controllers. The study details include: Study treatment: randomized to receive either GB-0895 or placebo administered every 6 months over 52 weeks. Visit frequency: every 1-2 months after the first month.
Key Dates
- Start date
- Dec 3, 2025
- Status verified
- Dec 2025
- Primary completion
- Dec 31, 2028
- Completion
- Dec 31, 2028
Study Design
- Enrollment
- 786 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: GB-0895GB-0895 Subcutaneous (SC) injection
- Placebo Comparator: PlaceboPlacebo Subcutaneous (SC) injection
Primary Outcome Measure
To evaluate the annualized asthma exacerbation rate (AAER) in adult and adolescent subjects with severe uncontrolled asthma. [ Time Frame: From Day 1 (randomization) to Week 52 ]
Central Contacts
- Generate Recruitment888-469-0033
Locations (34)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Research Site 23 | Northridge | California | 91324 | |
| Research Site 26 | Pasadena | California | 91105 | |
| Research Site 29 | Rancho Cucamonga | California | 91730 | |
| Research Site 34 | Valencia | California | 91355 | |
| Research Site 13 | West Hills | California | 91307 | |
| Research Site 15 | Colorado Springs | Colorado | 80923 | |
| Research Site 32 | Brooksville | Florida | 34613 | |
| Research Site 12 | Doral | Florida | 33122 | |
| Research Site 14 | Gainesville | Florida | 32607 | |
| Research Site 03 | Hialeah | Florida | 33016 | |
| Research Site 25 | Kendall | Florida | 33176 | |
| Research Site 04 | Miami | Florida | 33126 | |
| Research Site 01 | Miami Lakes | Florida | 33014 | |
| Research Site 08 | North Miami | Florida | 33169 | |
| Research Site 10 | Palm Springs | Florida | 33461 | |
| Research Site 02 | Tampa | Florida | 33613 | |
| Research Site 18 | Rincon | Georgia | 31326 | |
| Research Site 31 | Glenview | Illinois | 60026 | |
| Research Site 16 | Baltimore | Maryland | 21237 | |
| Research Site 28 | Columbia | Maryland | 21045 | |
| Research Site 20 | Towson | Maryland | 21204 | |
| Research Site 06 | Flint | Michigan | 48504 | |
| Research Site 30 | Olive Branch | Mississippi | 38654 | |
| Research Site 27 | Gastonia | North Carolina | 28054 | |
| Research Site 24 | Amarillo | Texas | 79106 | |
| Research Site 19 | Baytown | Texas | 77521 | |
| Research Site 07 | Dallas | Texas | 75230 | |
| Research Site 17 | Dallas | Texas | 75254 | |
| Research Site 09 | Houston | Texas | 77099 | |
| Research Site 11 | Houston | Texas | 77084 | |
| Research Site 22 | Kerrville | Texas | 78028 | |
| Research Site 05 | Lewisville | Texas | 75057 | |
| Research Site 33 | McKinney | Texas | 75069 | |
| Research Site 21 | Riverton | Utah | 84096 |
Find similar trials in Northridge, CA
By condition
By specialty
Related Studies
- Downstream Effects of Airway Mucus Plugs on 129Xenon MRI in Severe AsthmaRecruiting · Bastiaan Driehuys · Durham, North Carolina
- A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-2)PHASE3 · Recruiting · Generate Biomedicines · Bakersfield, California
- A Phase 2 Clinical Study to Evaluate the Efficacy and Safety of Frevecitinib (KN-002) in Patients With Severe AsthmaPHASE2 · Not Yet Recruiting · Kinaset Therapeutics Inc · Lancaster, California
- Evaluation of Ventilation Defects Downstream of Mucus Plugs in Patients With Severe AsthmaRecruiting · University of Kansas Medical Center · Kansas City, Kansas